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Abstract
Background: Many patients with human immunodeficiency virus infection use traditional, complementary, and
alternative medicines and other practices to combat the disease, with some also using prescribed antiretroviral
therapy provided by the public health sector. This study aimed to establish the awareness of public sector biomedical
health care providers on the use of traditional, complementary and alternative medicines by HIV-infected patients who
also used highly active antiretroviral therapy, and to determine whether this was based on patients seen or cases being
reported to them. Potential risks of interactions between the prescribed antiretroviral and non-prescribed medication
therapies may pose safety and effectiveness issues in patients using both types of treatment.
Methods: A descriptive cross-sectional study, using a researcher administered semi-structured questionnaire, was
conducted from June to August 2013 at ten public sector antiretroviral clinics in five regional, three specialised and
two district hospitals in eThekwini Health District, South Africa. Questionnaires were administered through face-to face
interview to 120 eligible participants consisting of doctors, nurses, pharmacists and post-basic pharmacist assistants in
HIV clinical practice. The results are presented as percent or proportion with standard error (SE), or as frequency.
Results: Ninety-four respondents completed the questionnaire, yielding a response rate of 78.3 %. Almost half (48/94)
were aware of patients using African traditional herbal medicines, over-the-counter supplements, unnamed complementary
Ayurveda medicines and acupuncture. Twenty-three of the 94 respondents (24.4 %) said they had consulted patients
who were using both antiretroviral therapy and certain types of non-prescribed medication in the previous three months.
Conclusions: Awareness among healthcare providers on patient use of traditional, complementary and alternative
medicines was relatively high. Few respondents had seen patients who used mostly African traditional medicines,
over-the counter supplements, and negligible complementary Ayurveda medicines and acupuncture, with caution
being advised in the interpretation of the former. Further research is needed to investigate communication between
healthcare providers and patients in this regard, and levels of acceptance of traditional, complementary and alternative
medicines by biomedical health care workers in HIV public sector practice.
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Background
While many patients in South Africa with human im-
munodeficiency virus (HIV) infection use traditional,
complementary and alternative medicines, there is a
scarcity of research among public sector biomedical
health care providers on their awareness of this practice,
and on the level of disclosure by patients. This study
aimed to establish the awareness of healthcare providers
about their HIV-infected patients’ use of traditional,
complementary and alternative medicines (TCAM) be-
sides other prescribed medication, and to determine
whether this was based on patients seen or cases being
reported to them. Access to highly active antiretroviral
therapy (HAART) by all those needing treatment is one
of the goals to fight the HIV pandemic in South Africa.
At of the end of 2012, two million people were estimated
to have access to HAART in the country [1]. With the
widespread use of HAART, HIV has been transformed
into a complex chronic disease, with patients living lon-
ger. While the benefits of antiretroviral therapy (ART)
are well established, the development of toxicity is one
of the limitations to treatment success [2]. In addition to
ART, many HIV infected patients also use complemen-
tary and alternative medicines to cope with the disease
[3], the extent of which is unknown.
Use of herbal therapies in KwaZulu-Natal Province
(KZN) was estimated in 2008 to be practiced by 36.6 %
of HIV-infected persons prior to starting HAART, at
8.0 % after six months, at 4.1 % after 12 months and
0.6 % after 20 months post initiation [4]. The use of
non-prescribed medicines by HIV-infected patients was
estimated at 15.6 % in patients on ART in Pretoria,
South Africa [5]. In Uganda, patients on HAART for less
than four years, and those who experienced antiretro-
viral related side-effects, were reported to be more likely
to use traditional herbal medicines [6].
According to the World Health Organization, Traditional
Medicines include “diverse health practices, approaches,
knowledge and beliefs incorporating plant, animal and/or
mineral based medicines, spiritual therapies, manual tech-
niques and exercises, applied singularly or in combination
to maintain well-being, as well as to treat, diagnose or pre-
vent illness [7].” The organization further defines comple-
mentary and alternative medicines as “abroad set of health
care practices that are not part of a country’s own tradition,
or not integrated into its dominant health care systems [8].”
However, the lack of disclosure of the use of TCAM to
health care providers is a cause of concern, with almost
one half of HIV-infected women in the United States
using any type of such medication not having discussed its
use to their biomedical health care providers [9]. A study
at two sites in South Africa reported 15.5 % (15/97) of
HIV-infected patients using traditional medicine and anti-
retroviral therapy, the majority of whom (92.9 %) chose
not to disclose their use to the public sector biomedical
health care providers [10]. Building a doctor-patient rela-
tionship, opening health care discussions, and obtaining
information are amongst the healthcare providers respon-
sibilities towards their patients [11]. Communication be-
tween health care providers and patients plays a key role
in addressing adverse events [12].
Patients may use TCAM for various reasons, such as
to strengthen immunity or improve general well-being,
as well as in cases where prescribed medication does not
work [13]. However, the potential for direct physical
harm is a real challenge, with contra-indications and the
negative interactions between some prescribed ART
medicines and natural products being described [14]. In
the private and public health sectors, doctors play an im-
portant role in managing HIV infected patients through
partnerships with them, and assistance is needed from
nurses, pharmacists, social workers, dieticians and sup-
port groups to ensure a holistic management of the pa-
tient [15]. In South Africa, the multidisciplinary team
caring for HIV-infected patients in the public health sec-
tor consists of doctors, nurses, pharmacists and post-
basic pharmacist assistants, amongst other health care
workers. As part of this holistic management, one of the
challenges facing the health care providers is ensuring
the safety of ART, which requires full disclosure of pre-
scribed medication and other non-prescribed medication
therapies used by HIV-infected patients. Challenges
brought about by using TCAM in combination with
allopathic ART calls for accurate information to be pro-
vided by the patient [16].
Many studies have reported on the self-reported use of
TCAM by patients, while this study explored the views
and experiences of the biomedical healthcare providers.
No contact was made with patients and traditional healers
who are also healthcare providers. Building on previous
work conducted in the eThekwini Health District [15, 16],
this study reports on the awareness of public health sector
biomedical healthcare providers about patient’s disclosure
of the use of TCAM besides other prescribed medication.
This was done in cases seen by four categories of health-
care providers among HIV-infected patients attending
public health sector antiretroviral clinics.
Methods
Study design, participants and sites
A descriptive cross-sectional study using a researcher ad-
ministered semi-structured questionnaire was conducted
from June to August 2013 at ten public accredited anti-
retroviral clinics within five regional, three specialised and
two district hospitals in eThekwini Health district, South
Africa. The provincial list of public accredited antiretro-
viral sites contained 16 locations in the eThekwini Health
District at the time of data collection, with this study
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being conducted in the ten sites where permission was
obtained from the relevant gate keepers.
Questionnaires were administered through face-to face
interview during clinic visit hours to 120 eligible partici-
pants, namely: doctors, nurses, pharmacists and post basic
pharmacist assistants (PBPA) in HIV clinical practice, who
had a minimum of three months work experience in HIV
clinical practice. To minimise sampling bias, assuming an
expected 10 % prevalence of awareness on the use of
TCAM among respondents within a ±5 % precision, an
estimated sample size of 138 was calculated following a
formula described in the literature [17]. The questionnaire
was pilot tested prior to data collection, and those partici-
pants who agreed to participate were requested to sign
consent before being interviewed. This study enrolled 120
eligible participants due to a scarcity of these four categor-
ies of biomedical healthcare providers at public antiretro-
viral sites. Respondents who did not answer all the
questions, due to their unavailability for leave or meeting
attendance within the study time frame, were excluded
from the final analysis. A group of nine final year phar-
macy students administered the questionnaire, which con-
sisted of questions on the following five categories: (i)
socio-demographic characteristics; (ii) awareness about
disclosure of prescribed treatments besides ART and non-
prescribed TCAM; (iii) biomedical healthcare providers’
reported cases with HIV-infected patients using both ART
and TCAM; (iv) reasons for uses and non-disclosure of in-
formation about TCAM by HIV-infected patients; (v) and
other pharmacovigilance related information. This was
done to establish possible interactions between antiretro-
viral medicines and use of TCAM, as described in the
South African standard treatment guidelines [18].
Statistical analysis
All collected data was entered into Excel and later ana-
lysed using the SPSS statistical programme for Windows,
version 20. The results are presented as percent or
proportion with standard error (SE), and relative error (RE).
If the relative standard error was0.50 or greater, the percent
was not stable and could not be reported when the number
of observed events in a given table cell is less than five.
Mean with standard deviation was reported for continuous
variables, while categorical variables were described as
frequency, with bar graph representation where applicable.
Ethics statement
This study received ethical approval under reference num-
ber SHSEC 030/13 from the School of Health Sciences,
University of KwaZulu-Natal. Permission was sought from
Department of Health and hospital management gate-
keepers before entering the premises of all surveyed health
facilities. Participation in the study was voluntary, and an
information sheet form was given to respondents who
signed informed consent. All questionnaires were coded
to ensure full anonymity of respondents and sites.
Results
Ninety-four respondents completed the questionnaire within
the study time frame, yielding a response rate of 78.3 %.
Socio-demographic characteristics
There were 25 doctors (26.6 %,), 29 nurses (30.9 %), 32
pharmacists (34.1 %) and eight post-basic pharmacist assis-
tants (8.5 %). The majority of respondents were female
(67/94) and had up to five years of work experience (53/
94). The overall mean professional experience was 5.9 years
(standard deviation ±4.4, range 0.4 to 22.0 years). Table 1
presents the socio-demographic characteristics of the
respondents.
Awareness about disclosure of prescribed treatments
besides ART and non-prescribed TCAM
Of the 94 respondents, 40 (42.5 %, SE0.078, RE0.001)
reported that HIV-infected patients disclosed the use of
other prescribed medication besides ART. Almost half of
Table 1 Socio-demographic characteristics of the health professional respondents (n = 94)
Category Sub-category Number, (%), SE, RE
Gender Female 67 (71.3 %), SE (0.055), RE (0.0008)
Male 27 (28.7 %), SE (0.087), RE (0.003)
Professional qualification Doctor 25 (26.6 %), SE (0.088),RE (0.033)
Nurse 29 (30.9 %),SE (0.086),RE (0.0027)
Pharmacist 32 (34.0 %), SE (0.084),RE (0.0024)
PBPA 8 (8.5 %), SE (0.099),RE (0.011)
Work experience(years) 0.3–5 53 (56.4 %),SE (0.068),RE (0.0012)
6–25 41 (43.6 %),SE (0.077),RE (0.0017)
Mean (standard deviation) 5.9 (±4.4)
Range (minimum -maximum) 0.3–22.0
Legend: SE = standard error, RE = relative error, PBPA = Post basic pharmacist assistant
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the respondents agreed that they were aware of patients
using African traditional herbal medicines, over-the-
counter supplements, unnamed complementary Ayurveda
medicines and acupuncture. In addition, 23 participants
(24.4 %) stated that they were familiar with such practices,
and had cases with patients using both antiretroviral ther-
apy and a few types of TCAM in the three months prior
to data collection. Table 2 indicates the number of doc-
tors, nurses, pharmacists and post basic pharmacist
assistants who reported being aware of the use by HIV
patients of other prescribed medication, besides ART, as
well as TACM medicines.
Figure 1 illustrates the types of TCAM (48/94) listed
by respondents as being used by HIV patients. They
consisted of certain African traditional herbal medicines,
over-the counter supplements, Ayurveda medicines and
acupuncture.
Biomedical healthcare providers’ reported cases with
HIV-infected patients using both ART and TCAM
Reported cases with patients who used both ART and
TCAM (23/94) consisted of the following medication
therapies: (i) Echinaforce® tablets (3); (ii) unnamed African
herbal mixtures (3); (iii) garlic (2); (iv) cancer bush (2); (v)
Vukuhlale (2); (vi) Stameta® (2); (vii) African potato (2);
(viii) immunadue® (2); (ix) over-the-counter centrum tab-
lets (2); (x) unnamed Ayurveda preparations (2); and (xi)
acupuncture (1).
Reasons for uses and non-disclosure of information about
TCAM by HIV-infected patients
Healthcare providers were asked to provide one per-
ceived main reason why they thought patients resorted
to using TCAM, with the results being presented in
Fig. 2. The respondents indicated that they thought pa-
tients reasons were mainly: boost their immune system
(7/23), cultural beliefs of beneficial effects of traditional
herbal mixtures (6/23), treatment of gastro-intestinal
side-effects, pain and chronic illness (5/23), nutrients
(2/23), relief of disease symptoms and improve survival
(2/23), and pressure from family members (1/23).
Respondents indicated the main reasons they thought
for non-disclosure of information about the use of
TCAM by HIV patients to biomedical healthcare pro-
viders, as illustrated in Fig. 3. Seven of the 94 respon-
dents (7.45 %) reported the use of TCAM practices as
perceived causes of adverse events. While very few doc-
tors (1/94) and pharmacists (1/94) perceived the use of
TCAM as main causes of adverse events, none of the
nurses and post basic pharmacist assistants listed the
use of TCAM as main causes of adverse events. One nurse
(1/94) viewed TCAM as alternate causes of adverse
events, while one doctor (1/94) and one nurse (1/94) listed
OTC supplements as main causes of adverse events. None
of the 23 respondents who had seen patients or heard
about them in their practice had also associated the use of
TCAM with adverse events and probable interactions with
prescribed antiretroviral medicines.
Discussion
Disclosure prevalence of the use of complementary and
alternative medicine among HIV-infected women was
estimated at 36 % in both pre- and post-HAART eras in
the United States [9]. Our findings, of few respondents
(24.4 %) having seen patients, or hearing about the use
of TCAM and prescribed ART, may be due to the de-
cline of self-reported use of herbal medicines by HIV-
Table 2 Healthcare workers’ awareness of the use of prescribed and non-prescribed medications by HIV patients
Respondent category (No) Aware of patient disclosure of all other prescribed medication Aware of patient
use of TCAM
Cases with patients using
both ART and TCAM
Doctors (n = 25) Yes 7 (7.45 %), SE (0.052), RE (0.007) 18 (19.15 %), SE (0.087),
RE (0.0045)
7 (7.45 %), SE (0.052), RE (0.007)
No 18 (19.15 %) 7 (7.45 %) 18 (18.08 %)
Nurses (n = 29) Yes 15 (15.96 %), SE (.0.068), RE (0.004) 19 (20.21 %), SE (0.075),
RE (0.0037)
6 (6.38 %), SE (0.046), RE (0.0072)
No 14 (14.90 %) 10 (10.64 %) 23 (24.47 %)
Pharmacists(n = 32) Yes 15 (15.96 %), SE (0.065), RE (0.004) 9 (9.45), SE (0.052),
RE (0.005)
7 (7.45 %), SE (0.052), RE (0.007)
No 18 (19.15 %) 23 (24.47 %) 25 (26.60 %)
PB PA (n = 8) Yes 3 (3.19 %), SE (0.165), RE (0.052) 2 (2.13 %), SE (0.051),
RE (0.024)
3 (3.19 %), SE (0.062), RE (0.019)
No 5 (5.32 %) 6 (6.38) 5 (5.32 %)
Total (n = 94) Yes 40 48 23
No 54 46 71
Legend: PBPA = post basic pharmacist assistant, TCAM = traditional, complementary and alternative medicines
Note: standard error calculated on the proportion of respondents who said yes to the question
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Fig. 1 Types of non-prescribed medication. Legend: ATM = African traditional herbal medicines, OTC = over-the-counter
Fig. 2 Perceived main reasons reported by healthcare providers for using non-prescribed medication by patients. Legend: ARV = Antiretroviral medicine,
TB = tuberculosis, HIV = human immunodeficiency virus
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infected patients following ARV initiation, as reported in
a cohort of HIV-infected patients in Kwazulu-Natal [4].
However, a relatively high rate of awareness among
healthcare providers about the use of African traditional
herbal medicines by HIV patients was found when com-
pared to another study in Uganda [19].
Regarding the reasons for use and non-disclosure,
poor communication between doctors and HIV-infected
patients was identified as a contributor to low rates of
disclosure of the use of traditional, complementary and
traditional medicines by patients to healthcare providers
in Uganda [19]. Non-disclosure of the use of herbal
medicines to medical doctors was estimated at 92.3 %
among HIV patients, who also reported never being
asked by their physician about their use of herbal medi-
cines in western Uganda [20]. The lack of proper com-
munication between patients and health care workers is
a real challenge, aggravated by negative perceptions and
attitudes of biomedical health care providers towards
traditional methods of care [21].
A holistic approach to managing HIV-infected patients
was discussed in a focus group with private sector
doctors as one of the factors to promote adherence to
antiretroviral therapy in the eThekwini Health District,
KwaZulu-Natal [15]. This included the need for doctors
and other health care workers to encourage the appro-
priate use of traditional medicine, provided that continu-
ity of antiretroviral therapy and potential drug-herb
interaction monitoring was assured. A greater awareness
about the use of traditional, complementary and alterna-
tive medicines among healthcare workers requires more
accurate information on what happens in real-life with
regard to such practices. While a study showed that bio-
medical health care providers in Durban antiretroviral
clinics admitted the personal use of traditional, comple-
mentary, and alternative medicines for various purposes
[16], this does not guarantee the safety and effectiveness
of such practices in patients on antiretroviral therapy. In
Trinidad, an assessment of the acceptance of herbal
medicines by physicians revealed that 40.6 % had used
this treatment modality [22]. In Alabama and Georgia
(USA) non-adherence to antiretroviral therapy was 1.69
times higher in HIV-positive women who used comple-
mentary and alternative medicines than among non-
users of such practices [23]. Other potential health risks
of complementary alternative medicines in HIV patients
were discussed in a study in UK, where, besides adher-
ence to antiretroviral therapy, serious drug interactions
with antiretroviral therapy or adverse effects of the rem-
edy used were reported with Echinacea, garlic, St John’s
wort and aloe vera [24].
Pharmacovigilance activities among health care workers
need to be informed by empirical evidence, based on peo-
ple’s activities and sound research. Although perceived
causality of adverse events due to the use of traditional,
complementary and alternative medicines was very low in
Fig. 3 Perceived main reasons reported by healthcare providers for non-disclosure of the use of TCAM by HIV-infected patients. Legend: TCAM= traditional,
complementary and alternative medicines
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this study, suggesting the difficulty of attributing them to
traditional, complementary and alternative medicines; a
study in Zimbabwe reported abdominal pain and rash in
association with the use of herbal remedies [25]. Occur-
rence of at least one or more adverse events related to
use/misuse of over-the-counter medication was also re-
ported among HIV-infected patients on antiretroviral
therapy in Texas, USA [26]. Further traditional, comple-
mentary and alternative medicine education for health
care workers is an important part of public health promo-
tion in poor constrained settings, as has been discussed in
developed world [27].
Strengths, limitations and generalizability of the study
Although we could not collect the expected response
rate of ≥ 80 %, a good response rate of 78.3 % was
achieved, compared to the 60 % being the goal for most
research of this type [28]. Missing information from
those participants who could not provide answers to all
questions within the study time frame was also a limita-
tion. A 100 % response rate may have revealed other
types of African traditional herbal medicines and other
practices used by patients in conjunction with prescribed
antiretroviral therapy. Views and experiences of other
healthcare providers such as social workers, psycholo-
gists, dieticians and lay counsellors were not assessed
despite their being part of a multidisciplinary team
caring for HIV patients. No attempt was made to access
patients’ medical records, which may have provided
other findings in patients seen or cases being reported to
healthcare providers. A larger and more inclusive sample
may have provided more information on awareness
about the use of traditional, complementary and alterna-
tive medicines among healthcare workers. The results of
this study cannot be assumed to accurately reflect the
TCAM practices of patients, and additional studies are
needed that obtain information from them in this
regard. Findings of this study cannot be generalised to
the entire HIV clinical practice.
Conclusions
Awareness among the biomedical healthcare providers
about the use of TCAM by HIV patients was relatively
high in the 10 public sector HIV clinics in eThekwini
Health District. However, only a few respondents had
seen patients who used them, most respondents indicat-
ing that they heard about such practices. The types of
TCAM used were mainly African traditional medicines
and over-the-counter supplements, while the use of
complementary Ayurveda medicines and acupuncture
practices was reported to be negligible. Regarding the po-
tential harm of natural products contributing to adverse
events and potential interactions with prescribed antiretro-
viral medicines, caution is advised in the interpretation of
our findings due to the few reported cases of patients on
using African traditional herbal medicines. Further re-
search is needed to investigate communication between
healthcare providers and patients in this regard, and atti-
tudes towards the use of traditional, complementary and
alternative medicines by biomedical healthcare providers in
HIV public sector practice for a more holistic approach to
HIV management.
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